ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,569.00
0.94%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Evaxion Biotech AS (EVAX)

  7. Evaxion Biotech AS (EVAX) Noticias

EVAX

Evaxion Biotech AS (EVAX)

Evaxion Biotech AS
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EVAX
FechaHoraFuenteTítuloSímboloCompañía
10/05/202416:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/05/202416:00GlobeNewswire Inc.Evaxion Receives Nasdaq NotificationNASDAQ:EVAXEvaxion Biotech AS
06/05/202416:01Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVAXEvaxion Biotech AS
17/04/202407:00GlobeNewswire Inc.Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01NASDAQ:EVAXEvaxion Biotech AS
02/04/202406:00GlobeNewswire Inc.Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus InfectionNASDAQ:EVAXEvaxion Biotech AS
27/03/202406:30GlobeNewswire Inc.Evaxion Announces Business Update and Full Year 2023 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
19/03/202406:30GlobeNewswire Inc.Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ PlatformNASDAQ:EVAXEvaxion Biotech AS
29/02/202406:30GlobeNewswire Inc.Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology InnovationsNASDAQ:EVAXEvaxion Biotech AS
20/02/202406:30GlobeNewswire Inc.Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDNASDAQ:EVAXEvaxion Biotech AS
07/02/202407:30GlobeNewswire Inc.Evaxion Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:EVAXEvaxion Biotech AS
06/02/202407:30GlobeNewswire Inc.Evaxion Announces Closing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
05/02/202408:09Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVAXEvaxion Biotech AS
01/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVAXEvaxion Biotech AS
01/02/202408:20GlobeNewswire Inc.Evaxion Biotech Announces Pricing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
31/01/202416:10Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
24/01/202407:30GlobeNewswire Inc.Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered TargetsNASDAQ:EVAXEvaxion Biotech AS
22/01/202415:30GlobeNewswire Inc.Evaxion Announces Completion of ADS Ratio ChangeNASDAQ:EVAXEvaxion Biotech AS
08/01/202407:30GlobeNewswire Inc.Evaxion Announces Plan to Implement ADS Ratio ChangeNASDAQ:EVAXEvaxion Biotech AS
21/12/202315:30GlobeNewswire Inc.Evaxion Biotech Announces Closing of Private PlacementNASDAQ:EVAXEvaxion Biotech AS
19/12/202315:15GlobeNewswire Inc.Evaxion Announces Business Update and Third Quarter 2023 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
19/12/202308:25GlobeNewswire Inc.Evaxion Biotech Announces Private Placement FinancingNASDAQ:EVAXEvaxion Biotech AS
28/11/202307:27GlobeNewswire Inc.Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine ConceptNASDAQ:EVAXEvaxion Biotech AS
15/11/202307:00GlobeNewswire Inc.Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer ImmunotherapyNASDAQ:EVAXEvaxion Biotech AS
06/11/202309:12GlobeNewswire Inc.Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan KhattakNASDAQ:EVAXEvaxion Biotech AS
31/10/202310:14GlobeNewswire Inc.Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01NASDAQ:EVAXEvaxion Biotech AS
26/10/202307:30GlobeNewswire Inc.New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be PresentedNASDAQ:EVAXEvaxion Biotech AS
05/10/202307:30GlobeNewswire Inc.Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:EVAXEvaxion Biotech AS
20/09/202307:26GlobeNewswire Inc.Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against GonorrheaNASDAQ:EVAXEvaxion Biotech AS
18/09/202307:23GlobeNewswire Inc.Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical companyNASDAQ:EVAXEvaxion Biotech AS
11/09/202307:17GlobeNewswire Inc.Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine DevelopmentNASDAQ:EVAXEvaxion Biotech AS
 Showing the most relevant articles for your search:NASDAQ:EVAX

Su Consulta Reciente

BIT
F17008
Vontobel Financial Produ...
NASDAQ
MMZIX
Mass Mutual Select T Row...
BIT
UV4KYV
UniCredit Bank
BOV
B3SA3Q
B3 SA - Brasil Bolsa Bal... ON
EU
MLCOT
Coretech 5
BOV
BVLU39R
BlackRock Institutional ...
NASDAQ
PSHG
Performance Shipping
BOV
GPSI34M
GAP DRN
USOTC
HGSFF
Hang Seng Ftse Xinhua Ch... (GM)
AMEX
NEWP
New Pacific Metals
NASDAQ
EH
EHang
BMF
DIIN24V26
DIIN24V26 - 07/2024
ASX
HMCO
HMC Capital
NASDAQ
LOVE
Lovesac
USOTC
BLXX
Biox (CE)
NASDAQ
ABAGTXX
Royal Bank of Canada Dua...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados